927P Patients (pts) with Recurrent And/or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) Treated with Nivolumab (NIVO) in the First-Line (1L) or Later-Line (2L+) Settings in Germany: Updated Results from the Real-World HANNA Study
Annals of Oncology(2023)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined